Acuamark Diagnostics, Inc
AcuamarkDx is developing unique tests to accurately detect early cancer from blood when it can be cured - first for CRC early detection, then for all-cancers.
AcuamarkDx is developing first-in-kind, highly-accurate, affordable and scalable blood tests to detect early-stage cancer when it can be cured.
AcuamarkDx's first product is a blood test for early-stage detection of colorectal cancer (CRC). Its second product is an all-cancer early detection blood test.
AcuamarkDx has demonstrated detection proof-of-concept on human plasma samples from confirmed CRC patients.
(Offices: New York)